Chilean biotech GeneproDX can substantially increase the prediction accuracy of detecting thyroid cancer and dramatically reduce the need for surgery which is currently used to confirm cancer diagnosis in indeterminate nodules. ______________________________________________________________ Thyroid nodules are widespread; particularly among people aged 60 years and older. In fact, it’s estimated that up to 50% of people over…
Read moreChilean GeneproDX is ready to go global with its patented ThyroidPrint®
